US Edition
Published • loading... • Updated
Catheter Precision Expands European Footprint with Landmark LockeT Procedures in France and Secures VIVO Purchase Ord...
Summary by csimarket.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Catheter Precision Expands European Footprint with Landmark LockeT Procedures in France and Secures VIVO Purchase Ord...
'Innovative Expansion: Catheter Precision's Strategic Growth in Europe' Catheter Precision, Inc. (NYSE: VTAK), a U.S.-based medical device company at the forefront of cardiac electrophysiology solutions, continues to break new ground with its recent advancements in Europe. Notably, the company has achieved a significant milestone with the completion of its first LockeT procedures in France. This momentous event underscores Catheter Precision's s…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
